MAILAND–(BUSINESS WIRE)–Nach dem Abschluss einer Serie-B-Finanzierungsrunde durch AAVantgarde hat AGC Biologics eine neue Produktionsvereinbarung mit dem Biotechnologieunternehmen bekannt gegeben. Damit hat AGC Biologics einen weiteren Meilenstein au…
AGC Biologics produrrà terapie geniche a doppio vettore di AAVantgarde mirate alle retinopatie ereditarie
MILANO–(BUSINESS WIRE)–Dopo la chiusura di un round di finanziamento di serie B da parte di AAVantgarde, AGC Biologics ha annunciato un nuovo accordo di produzione con l’azienda biotech, che rappresenta il progresso più recente di AGC Biologics nel m…
Uncategorized
Newer players update the basics in dry eye treatment
Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to get the job done. It makes me chuckle when I see modern medications that have little or nothing to do with tear volume evaluate…
Uncategorized
Newer players update the basics in dry eye treatment
Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to get the job done. It makes me chuckle when I see modern medications that have little or nothing to do with tear volume evaluate…
Uncategorized
‘A historic moment’: Medical societies unite at Lifestyle Medicine Conference
DALLAS — Leaders of several medical organizations came together at the American College of Lifestyle of Medicine’s annual conference to highlight the importance of integrating lifestyle medicine across all of health care.Padmaja Patel, MD, DipABLM, FAC…
AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
MILAN–(BUSINESS WIRE)– #Biotech–On the heels of AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking AGC Biologics’ latest advancement in the adeno-associated v…